CAMBIAR INVESTORS LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAMBIAR INVESTORS LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$24,310,009
-5.9%
238,661
-6.8%
1.03%
-5.3%
Q2 2023$25,828,247
-8.8%
255,953
-16.8%
1.09%
-10.5%
Q1 2023$28,308,952
+2.6%
307,706
+1.2%
1.22%
-3.1%
Q4 2022$27,597,659
+9.9%
304,207
-7.9%
1.26%
-0.6%
Q3 2022$25,102,000
-85.7%
330,248
-85.2%
1.26%
-50.7%
Q3 2016$176,023,000
+0.8%
2,229,270
+5.3%
2.56%
+3.4%
Q2 2016$174,700,000
+27.7%
2,117,314
+12.1%
2.48%
+26.4%
Q1 2016$136,775,000
+44.2%
1,888,116
+71.2%
1.96%
+43.9%
Q4 2015$94,868,000
+18.5%
1,102,602
+26.6%
1.36%
+15.3%
Q3 2015$80,086,000
-41.1%
871,262
-37.0%
1.18%
-38.1%
Q2 2015$136,029,000
+8.9%
1,383,250
+9.2%
1.91%
+5.4%
Q1 2015$124,938,000
-13.6%
1,266,990
-18.8%
1.81%
-17.5%
Q4 2014$144,529,000
-4.2%
1,559,773
-2.6%
2.20%
+1.9%
Q3 2014$150,797,000
+3.8%
1,602,006
-0.2%
2.16%
+6.3%
Q2 2014$145,262,000
+4.4%
1,604,574
-2.0%
2.03%
-1.4%
Q1 2014$139,136,000
+12.0%
1,636,505
+5.9%
2.06%
+12.3%
Q4 2013$124,193,000
+12.1%
1,545,068
+7.0%
1.83%
+1.1%
Q3 2013$110,749,000
+6.8%
1,443,739
-1.5%
1.81%
+8.3%
Q2 2013$103,652,000
+609.3%
1,465,871
+614.6%
1.67%
+615.0%
Q1 2013$14,614,000205,1370.23%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders